Analytical Data
-
Gene name
GPLD1
- Application
-
Alternative Names
GPLD1；PIGPLD1；Phosphatidylinositol-glycan-specific phospholipase D
-
Species
Human
-
Source
E. coli
-
Tag
N-terminal His-Tag
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P80108
-
Expression Region
1-176aa
-
AA Sequence
MSAFRLWPGLLIMLGSLCHRGSPCGLSTHIEIGHRALEFLQLHNGRVNYR ELLLEHQDAYQAGIVFPDCFYPSICKGGKFHDVSESTHWTPFLNASVHYI RENYPLPWEKDTEKLVAFLFGITSHMAADVSWHSLGLEQGFLRTMGAIDF HGSYSEAHSAGDFGTVYLHLLNFLVV
-
Molecular Weight
23.2kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Identification
Protein Description
GPLD1, or glycosylphosphatidylinositol-specific phospholipase D1, is an important enzyme involved in the metabolism of membrane lipids, specifically in the hydrolysis of glycosylphosphatidylinositols (GPIs), which anchor various proteins to the cell membrane. Its role extends beyond lipid metabolism; GPLD1 is implicated in cell signaling processes and immune responses, making it a critical player in both normal physiological functions and pathological conditions. Research on GPLD1 has gained momentum due to its potential significance in various diseases, including cancer, neurodegenerative disorders, and infections, where altered GPLD1 activity could influence disease progression and treatment outcomes. The recombinant expression of GPLD1 offers a valuable tool for studying its enzymatic properties and biological functions in detail. By producing GPLD1 in a controlled laboratory setting, researchers can investigate its biochemical characteristics, interactions with lipid substrates, and regulatory mechanisms. Furthermore, the generation of recombinant GPLD1 provides a platform for developing potential therapeutic agents that could modulate its activity, offering new avenues for treatment strategies targeting diseases associated with dysfunctional lipid metabolism or immune responses. Understanding the functional roles and regulatory pathways of GPLD1 through recombinant studies can yield insights into cellular processes and lead to advancements in biomedical research and therapeutic interventions.
